BIOMAT Database Logo BIOMAT Database Logo

[Does platelet derived growth factor induce myelofibrosis in agnogenic myeloid metaplasia?]. 1987

H Teplizky, and A Dvilansky

UI MeSH Term Description Entries
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

H Teplizky, and A Dvilansky
Progressive myelofibrosis in agnogenic myeloid metaplasia.
November 1983, Archives of pathology & laboratory medicine,
H Teplizky, and A Dvilansky
SPLENECTOMY FOR AGNOGENIC MYELOID METAPLASIA AND MYELOFIBROSIS.
February 1965, Archives of surgery (Chicago, Ill. : 1960),
H Teplizky, and A Dvilansky
Metastatic carcinoma simulating agnogenic myeloid metaplasia and myelofibrosis.
November 1969, Cancer,
H Teplizky, and A Dvilansky
Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis.
March 1983, British journal of haematology,
H Teplizky, and A Dvilansky
Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis.
December 1999, Mayo Clinic proceedings,
H Teplizky, and A Dvilansky
Concomitant myelofibrosis with agnogenic myeloid metaplasia and malignant lymphoma.
September 1983, Mayo Clinic proceedings,
H Teplizky, and A Dvilansky
Acute myelofibrosis. An accelerated variant of agnogenic myeloid metaplasia.
February 1971, Annals of internal medicine,
H Teplizky, and A Dvilansky
Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
January 1991, British journal of haematology,
H Teplizky, and A Dvilansky
Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients.
February 1997, Leukemia research,
H Teplizky, and A Dvilansky
[Agnogenic myeloid metaplasia].
September 1952, Revista medica de Costa Rica,
Copied contents to your clipboard!